Search

(D1) Optimizing the Use of JAK Inhibitors in Dermatology: Real-World Evidence, Indication Expansion, and Managed Care Strategies for Moderate Disease Management

Inhibitors in Dermatology: Real-WorldEvidence, Indication Expansion, and … Inhibitors in Dermatology: Real-WorldEvidence, Indication Expansion, and …
Precision Medicine in Breast Cancer: Navigating Access, Evidence, and Emerging Therapies in Managed Care

Cancer: Navigating Access, Evidence, and Emerging Therapies in … therapies and the growing body of real-worldevidence that supports managed care … application of precision oncology evidence and strategies for integrating …
AMCP California - Precision Medicine in Breast Cancer: Navigating Access, Evidence, and Emerging Therapies in Managed Care

Cancer: Navigating Access, Evidence, and Emerging Therapies in … therapies and the growing body of real-worldevidence that supports managed care … application of precision oncology evidence and strategies for integrating …
RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions

Real-worldevidence (RWE), generated fromreal-world data (RWD), has great potential … to expand the totality of evidence and bridge the gap between …
Managed Care Perspectives on Achieving Diabetes Treatment Goals Using New Monitoring Technology

decision-making with current evidence and patient-specific factors … equitable treatment selection. Real-world case-based scenarios are … decision-making with current evidence and patient-specific factors …
Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management

insights from a health plan’s real-world experience with integrated … insights from a health plan’s real-world experience with integrated …
Beyond the Buzzwords: What We Learned Bridging Pharmacy, Quality, AI, and Data Science to Improve Performance

moves beyond jargon to share real-world lessons from managed care … moves beyond jargon to share real-world lessons from managed care …
Tuesday, 10/27 - Sessions from 10:15-11:30am

Inhibitors in Dermatology: Real-WorldEvidence, Indication Expansion, and …

You are here